alt
      alt
      alt
          View all results
          Stethoscope with light burst.

          FOCUS Magazine 2018

          In our 2018 edition of FOCUS, we explore ways to effectively use data from real-world evidence studies, how therapy decisions in oncology can be impacted by real-world data and the role that real-world treatment patterns play in the development of new treatment options in rheumatology.

          Browse Focus Magazine

           

          Focus Magazine

          Man writing on a pad of paper.

          Letter from the editor

          Dr. Bruce Feinberg provides insight into our latest issue of FOCUS, as we explore the capabilities of real-world evidence and how its application is increasing the value of care in today’s healthcare marketplace.
          Doctor wearing a stethoscope consulting with a patient.

          Real-World Trends in Disease Management

          Systemic Lupus Erythematosus (SLE) is an autoimmune disease that triggers inflammation in body tissues. Since SLE is a relatively rare condition adversely affecting the young and productive population, understanding real-world treatment patterns and care gaps is important to guide the development of new treatment options for this debilitating disease.
          Nurse sharing a file with a patient.

          Real-World Evidence: Why and How

          Much has been written in recent years about the advantages and challenges of real-world evidence (RWE) studies, and how best to utilize the data generated, moving forward. To help us better understand the process and to shed some light on RWE studies, Dr. Chadi Nabhan sits down with Dr. Anthony Mato, Associate Attending and CLL Program Director at the Memorial Sloan Kettering Cancer Center in New York.
          Two physicians looking at a paper report.

          Use of RWE in Making Therapy Decisions

          Providers are recognizing that real-world data and real-world evidence are rapidly entering their clinical practice workflows and starting to affect compensation. Our research explores how RWD and RWE are understood by oncology providers and their perceptions of its utility.